licenses or other rights.
2
SCHEDULE 6
Notices
(a)
If to Sanofi or Sanofi Amerique:
Aventis Pharmaceuticals Inc
200 Crossing Boulevard
Bridgewater
New Jersey 08807
USA
Attention: President R&D
Copy: General Counsel
With a copy to:
sanofi-aventis
174 Avenue de France
Paris, France 75017
Attention: General Counsel
(b)
If to Regeneron:
Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, New York 10591
U.S.A.
Attention: President Copy: General Counsel
With a copy to:
Skadden, Arps, Slate, Meagher & Flom LLP
One Beacon Street, 31st Floor
Boston, Massachusetts 02108
Attention: Kent A. Coit
1